Cite
HARVARD Citation
Tinker, A. et al. (n.d.). O007/#456 Post-hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab. International journal of gynecological cancer. pp. A5-A6. [Online].